A formulary for pediatric oncology in developing countries

Pediatr Blood Cancer. 2005 May;44(5):433-5. doi: 10.1002/pbc.20367.
No abstract available

MeSH terms

  • Antineoplastic Agents / economics
  • Antineoplastic Agents / therapeutic use
  • Child
  • Developing Countries
  • Humans
  • Neoplasms / drug therapy*
  • Patient Rights / ethics
  • World Health Organization

Substances

  • Antineoplastic Agents